Solensia® for Cats: A New Way to Treat Arthritis Pain

Introduction

Cats are masters at hiding pain.

Unlike dogs, they rarely limp or cry when arthritis develops. Instead, they quietly stop doing the things they once loved—jumping onto the windowsill, climbing the cat tree, chasing toys, or greeting you at the door.

Many owners assume their cat is “just slowing down with age.”

In reality, many senior cats are living with chronic osteoarthritis pain.

One of the newest treatments available is Solensia®, a monthly injectable medication specifically developed for cats with osteoarthritis pain.

Like Librela® in dogs, Solensia belongs to a newer class of medications called monoclonal antibodies. Rather than treating inflammation directly, it targets one of the body's major pain pathways.

For many cats, the changes can be surprisingly subtle—but incredibly meaningful.

Owners often tell me:

“He's jumping onto the bed again.”

“She's grooming herself like she used to.”

“He's playing with toys for the first time in years.”

At the same time, every medication has potential benefits and potential risks. Understanding both helps owners make informed decisions together with their veterinarian.

What Is Solensia?

Solensia is a monthly injectable monoclonal antibody approved for the control of osteoarthritis pain in cats.

Rather than affecting many different body systems, Solensia targets a single protein involved in pain transmission called Nerve Growth Factor (NGF).

What Is Nerve Growth Factor?

NGF is a naturally occurring protein that becomes elevated in painful arthritic joints.

As NGF binds to pain receptors, it amplifies pain signals traveling from the joint to the brain.

Think of it like turning the volume knob higher on pain.

Solensia binds to NGF before it reaches its receptor, reducing the intensity of pain signals.

It does not repair damaged cartilage.

It does not cure arthritis.

It helps cats experience less pain while living with arthritis.

How Is Solensia Different From Traditional Pain Medications?

Traditional medications often reduce inflammation or affect multiple pain pathways.

Solensia works differently.

It specifically targets NGF, reducing pain signaling without acting like a traditional NSAID.

For many cats—especially those with concurrent diseases such as chronic kidney disease—this different mechanism of action may make it an appropriate option, although every cat should be evaluated individually by a veterinarian.

What Can Owners Expect?

Every cat responds differently.

Some owners notice changes within the first few weeks.

Others observe gradual improvement over the first two or three monthly injections.

The changes are often behavioral rather than dramatic.

Owners frequently notice:

• Jumping onto furniture again
• Improved grooming
• More interaction with the family
• Better mobility
• Increased willingness to climb stairs
• More interest in toys
• Improved comfort while resting
• Better overall attitude

Sometimes the biggest improvement is simply:

“My cat acts like herself again.”

Who Is a Good Candidate?

Solensia may be appropriate for cats with osteoarthritis pain, particularly those who:

• Have confirmed arthritis
• Have difficulty taking daily medications
• Need long-term pain management
• May not be ideal candidates for long-term NSAID therapy
• Benefit from a multimodal arthritis management plan

Your veterinarian will determine whether Solensia is appropriate based on your cat's medical history, physical examination, and overall health.

Are There Side Effects?

Like every medication, Solensia has potential risks as well as potential benefits.

Many cats tolerate Solensia well and experience meaningful improvements in comfort and mobility.

However, owners should understand both the common side effects and the less common but more serious adverse events reported after approval.

Commonly Reported Side Effects

Commonly reported reactions include:

• Vomiting
• Diarrhea
• Injection-site discomfort
• Mild lethargy
• Decreased appetite

These are often mild and temporary, but your veterinarian should be informed if they occur.

Serious Adverse Events Have Been Reported

Rare but serious adverse events have also been reported through post-marketing safety monitoring.

Reported events have included:

• Difficulty walking
• Weakness
• Seizures
• Collapse
• Severe lethargy
• Death in rare reported cases

As with Librela, post-marketing reports do not prove that Solensia caused every reported event. Many cats receiving Solensia are elderly and have multiple concurrent medical conditions.

Nevertheless, these reports are important and should be part of the discussion before beginning treatment.

When Should You Contact Your Veterinarian?

Contact your veterinarian promptly if your cat develops:

Monitoring Your Cat

Although routine bloodwork monitoring is not required specifically because of Solensia, regular veterinary examinations remain important.

Regular monitoring helps ensure your cat continues to receive the most appropriate care as arthritis changes over time.

Your veterinarian may evaluate:

• Mobility
• Body weight
• Muscle condition
• Grooming behavior
• Activity level
• Pain assessment
• Overall quality of life

Treatment plans may be adjusted over time as arthritis progresses or other health conditions change.

Is Solensia a Cure?

No.

Solensia does not reverse arthritis or regenerate damaged cartilage.

Instead, it reduces pain so cats can move more comfortably and enjoy their normal behaviors again.

For many cats, that means:

• Better mobility
• More jumping
• Better grooming
• More interaction
• Greater confidence
• Improved quality of life

Like every arthritis treatment, Solensia works best as part of a comprehensive management plan that may include weight management, environmental modifications, and regular veterinary care.

Dr. Rene's Perspective

Take-Home Message